Your Encore Blog

  • The Power of Community: Dispelling the Loneliness of the Freelance Lifestyle

    The Power of Community: Dispelling the Loneliness of the Freelance Lifestyle

    When “matches” are made based on algorithms, reverse auctions, and keywords, the human connection is lost. But it is human connection that fuels individual inspiration, rejuvenation, reinvention...

    Read Article
  • Of Clouds and Communities: Connecting Talent and Work in the Gig Economy

    Of Clouds and Communities: Connecting Talent and Work in the Gig Economy

    In the frenzy to capitalize on this trend, technology is rapidly becoming the lead “solution” for connecting freelancers and employers.

    Read Article
  • Improving R&D Productivity with Activity Based Costing

    Improving R&D Productivity with Activity Based Costing

    Today’s prevailing wisdom is that R&D costs are on the rise while ROI on those investments are down. The Tufts Center for the Study of Drug Development puts the total costs of new drug...

    Read Article
  • How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20 of The Pharmcast)

    How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20 of The Pharmcast)

        In this episode of The Pharmcast, we join YourEncore Expert, Darryl Glover, to discuss one of the hottest technologies on the market today: blockchain. We've heard some people...

    Read Article
  • Ten Tips for Enterprise Technology Adoption in Pharma

    Ten Tips for Enterprise Technology Adoption in Pharma

    The RFP processes are robust, the ROI models are compelling, the software is best of breed, and the expectations are high. So, why do so many software deployment programs in Pharma fail...

    Read Article
  • State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

    State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

      In this episode of The Pharmcast, we share a recording from our May 5th webinar, State of the Industry: U.S. Regulatory Policy Overview. Parthenon-EY and YourEncore recently...

    Read Article
  • The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

    The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

      This week on The Pharmcast, we catch up with Dr. Tim Franson to discuss the leading edge of rare disease drug development. Dr. Franson has been actively helping Parent Project...

    Read Article
  • YourEncore Announces Addition of Michelle DeJonge and Dr. James Wood as Strategic Advisors for Medical Devices & Diagnostics Practice

    YourEncore Announces Addition of Michelle DeJonge and Dr. James Wood as Strategic Advisors for Medical Devices & Diagnostics Practice

    INDIANAPOLIS, IN--YourEncore (www.yourencore.com), a company that helps firms in the life sciences, consumer products and food sciences industries solve complex innovation, compliance...

    Read Article
  • Welcome to the Real World: A Reality Check for Digital Health with Dr. Ron Razmi (Ep. 17 of The Pharmcast)

    Welcome to the Real World: A Reality Check for Digital Health with Dr. Ron Razmi (Ep. 17 of The Pharmcast)

      This week on The Pharmcast, we tackle one of the hottest topics in the life sciences and healthcare industry: digital health. The promise of digital health is enticing, and a...

    Read Article
  • 7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)

    7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)

      On this episode of The Pharmcast, Heidi Youngkin shares seven best practices for successful biologic launch communication. When it costs over $2.5B dollars to develop a drug,...

    Read Article
  • The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

    The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

    On this week's episode of The Pharmcast, we talk with YourEncore Expert, Philippe Barzin, on the future of big data and artificial intelligence in oncology. Based off Philippe's...

    Read Article
  • Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

    Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

    On this week's episode of The Pharmcast, we explore the key elements of an effective regulatory strategy and how to drive value to patient and shareholders by working with the FDA. We...

    Read Article
  • Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

    Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

    We are at a time of great change and transition in the FDA. The sitting FDA chief stepped down, just when the 21st Century Cures Act passed into law; PDUFA 6 is up for renewal this...

    Read Article
  • Executive Briefing: EU Medical Device Regulation | 5 Ways EU MDR Will Impact Your Business [White Paper]

    The European Union has agreed on a new Medical Device Regulation meant to improve patient safety and data  transparency. The regulation is extensive and impactful – it touches many...

    Read Article
  • NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

    NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

    Read Article
  • Medtech Valuation Killers: 10 Regulatory & Commercialization Traps to Avoid (Ep. 11 on The Pharmcast)

    Medtech Valuation Killers: 10 Regulatory & Commercialization Traps to Avoid (Ep. 11 on The Pharmcast)

    Read Article
  • Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

    Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

    This week on The Pharmcast, we turn our attention to the topic of rare disease, and more specifically: how to engage and educate rare disease patients to advance development. It's...

    Read Article
  • No Surprises: Improving Medical Devices Due Diligence (Ep. 9 on The Pharmcast)

    No Surprises: Improving Medical Devices Due Diligence (Ep. 9 on The Pharmcast)

    This week on The Pharmcast, we discuss areas often overlooked in due diligence efforts that can lead to expensive or even show-stopper surprises once the acquisition is complete and...

    Read Article
  • FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 on The Pharmcast)

    FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 on The Pharmcast)

    This week on The Pharmcast, we explore best practices and common pitfalls in FDA 483 Responses.  In 2015, there were an average of 175 inspections and 10 warning letters issued per...

    Read Article
  • Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr. Don Therasse  (Ep. 7 on The Pharmcast)

    Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr. Don Therasse  (Ep. 7 on The Pharmcast)

    This week on The Pharmcast, we talk with Dr. Don Therasse, former VP of Global Patient Safety for Eli Lilly & Company, and current Strategic Advisor for YourEncore. With over 26...

    Read Article
  • loading
    Loading More...